Cell cycle inhibitors work by interfering with the activity of cyclins and CDKs. For instance, CDK inhibitors, such as palbociclib and ribociclib, specifically inhibit the activity of CDKs, preventing the phosphorylation of target proteins necessary for cell cycle progression. This results in the arrest of the cell cycle, particularly at the G1/S checkpoint.
